Cargando…
TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
Background: Chagas cardiomyopathy is caused by Trypanosoma cruzi (Tc). Two antigenic candidates, TcG2 and TcG4, are recognized by antibodies in naturally infected dogs and humans; and these vaccine candidates provided protection from Tc infection in mice and dogs. Trypanosoma rangeli (Tr) is non-pat...
Autores principales: | Gupta, Shivali, Salgado-Jiménez, Berenice, Lokugamage, Nandadeva, Vázquez-Chagoyán, Juan Carlos, Garg, Nisha Jain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606718/ https://www.ncbi.nlm.nih.gov/pubmed/31293599 http://dx.doi.org/10.3389/fimmu.2019.01456 |
Ejemplares similares
-
Prophylactic Efficacy of TcVac2 against Trypanosoma cruzi in Mice
por: Gupta, Shivali, et al.
Publicado: (2010) -
Immune Protection against Trypanosoma cruzi Induced by TcVac4 in a Canine Model
por: Aparicio-Burgos, José E., et al.
Publicado: (2015) -
TcVac3 Induced Control of Trypanosoma cruzi Infection and Chronic Myocarditis in Mice
por: Gupta, Shivali, et al.
Publicado: (2013) -
Experimental Nanovaccine Offers Protection Against Repeat Exposures to Trypanosoma cruzi Through Activation of Polyfunctional T Cell Response
por: Chowdhury, Imran H., et al.
Publicado: (2020) -
The TcI and TcII Trypanosoma cruzi experimental
infections induce distinct immune responses and cardiac fibrosis in
dogs
por: Duz, Ana Luiza Cassin, et al.
Publicado: (2014)